🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

👉 Are you interested in #BreastCancer? Have a look at the second edition of Breast Cancer: Essentials for Clinicians. Written for young #oncologists and free to download for ESMO members! #oncologyeducation 🔗 ow.ly/RkAQ50VSirA

In her Keynote Lecture at #ESMOBreast25, Sherene Loi, MD considers the question of who truly benefits from #immunotherapy in #BreastCancer, noting that success hinges on careful definition of responsive patient subgroups Full article in the #ESMODailyReporter ow.ly/Xbc850VSxZi

Having major #ESMOBreast25 FOMO! Congratulations to friends & colleagues on wonderful presentations; thanks to other for sharing it all here for me to follow! 🙏💕 Erika Hamilton, MD Sherene Loi, MD Kevin Kalinsky, MD, MS, FASCO Matteo Lambertini, MD PhD Kevin Punie Sara Tolaney Dr. Kelly Shanahan Janice Cowden G Curigliano MD PhD

🔍 What's the role of surgery, radiotherapy & systemic therapy in oligometastatic STS? This expert review explores current evidence & future directions. 🧠 Read now: oaepublish.com/articles/2394-… #STS #Sarcoma #CancerCare #Oligometastasis #Oncology

Full room for the first session of #ESMOBreastBCY during #ESMOBreast25 Two half days of discussion completely focused on the management of young patients affected by breast cancer! OncoAlert ESMO - Eur. Oncology Ann Partridge MD, MPH Fedro Peccatori MD, PhD Tanja Spanic YoungSurvivalCoaliti Europa Donna

Last post from #ESMOBreast25…I’m deeply grateful & really honored for the opportunity to chair together with Dr. Shani Paluch-Shimon the #ESMOBreastBCY sessions…2 days that have brought together the #oncology community caring for #BreastCancer in young women! ESMO - Eur. Oncology OncoAlert

📣 #ESMOFellowship: Check out the practical tips from Teresa Amaral, MD, PhD and Evandro de Azambuja, MD, PhD on how to make your application stand out. 📅 Apply by 29 May 2025 at 12.00 AM CEST 🔗 ow.ly/gNUS50VV2yB

🚨🥁Exciting Nature Medicine Publication Announcement 👉Hot off the press on this #ClinicalTrialsDay ! Thrilled to share our Nature Medicine paper: "Cancer treatment paradigms in the precision medicine era" 👉We propose 5 BOLD strategic recommendations to modernize cancer

💥 “If you want easy, oncology isn’t it. But if you thrive on challenge – start now.” 💥 Dr Elene Mariamidze shares her journey through mentorship, resilience & patient-centred care in this inspiring Q&A touchoncology.com/insight/dr-ele… Elene Mariamidze ESMO - Eur. Oncology Axel S. Merseburger #Oncology

Heart matters!🫀❤️ #Cardioprotection in #anthracycline treated #BreastCancer patients: final analysis from the 2x2 randomized, placebo-controlled, double-blind SAFE trial Article link: authors.elsevier.com/sd/article/S20… Università di Firenze Azienda Ospedaliero-Universitaria Careggi ESMO Open OncoAlert #OncoAlert

Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer in ESMO Open. 101 patients with solid tumors, ORR 77%, mDOR and mPFS 59 and 61 months, respectively. 88% of patients with TRAES, 26% of G3 or higher esmoopen.com/article/S2059-…

#ESMOMembers vote for the leaders who will shape ESMO’s future. Vote now for the Directors of Education, Public Policy & Membership - and the Chair and members of the Nomination Committee 📽️ Watch the ESMO President’s message 🔗 Vote now: ow.ly/XX3W50VZQyL FabriceAndre

Two major clinical trials are setting new standards in the treatment of #AnalCancer and #RectalCancer showing promising outcomes w/ reduced-dose chemoradiotherapy & non-surgical strategies. Read the news in the #ESMODailyReporter 🔗 ow.ly/7n9s50W1nFk #LowerGICancer

3rd NEJM publication for #bcsm at #ASCO25 in the last 2 days (that I'm aware of!). #camizestrant #ESR1 Come to plenary Hall B1 today at 1pm to hear the presentation by Dr. Turner and discussion about potential impact by Angie DeMichele, MD, MSCE, FASCO! nejm.org/doi/full/10.10…

Fantastic discussion by Angie DeMichele, MD, MSCE, FASCO at the #ASCO25 plenary session about the #SERENA6 trial…definitely promising data but likely too early to change practice OncoAlert #bcsm #BreastCancer #ESR1m

No comments needed 🤩🥳😍 congrats super Sara Tolaney from Dana-Farber and all involved in the #DB09 trial !!!! #ASCO25 OncoAlert ASCO Dana-Farber’s Breast Oncology Center

One more NEJM paper for the #BreastCancer community at #ASCO25: very important data with use of #elinzanetant to help patients struggling with vasomotor symptoms during endocrine therapy OncoAlert

Maxi-studio guidato da Ospedale San Martino Genova con sostegno di Fondazione AIRC per la ricerca sul cancro: mastectomia bilaterale e ovariectomia riducono fino al 42% il rischio di recidiva e mortalità anche in donne #BRCA mutate già colpite da #tumorealseno in giovane età. 👉ospedalesanmartino.it/it/ricerca-sci… @TheLancetOncology

On #WorldEnvironmentDay, ESMO stands w/ the global community to #BeatPlasticPollution. #Microplastics are found in organs and tumours. More research needed to understand their role in cancer development Pawel Sobczuk 🔗 ow.ly/Q8xT50W3VCP #ESMODailyReporter

Check out this recent review on the management of metastatic hormone receptor-positive #BreastCancer Beyond CDK4/6 Inhibitors. 🔓pubmed.ncbi.nlm.nih.gov/40434676/ ✍️Antonio Giordano, MD PhD Erica Mayer Sara Tolaney Paolo Tarantino Ilana Schlam @AnaGarridoCastro